20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CANAGLIFLOZIN, with a corresponding US DMF Number 30964.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 09, 2016, and payment made on September 23, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II